Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06873581 · ClinicalTrials.gov registry record · Phase 3
Pivotal Study of Voro Urologic Scaffold
A Phase 3 study of Radical Prostatectomy and Stress Urinary Incontinence (SUI), sponsored by Levee Medical.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 266
- Enrollment target
- 20
- Study locations
NCT06873581 is a Phase 3 study of Radical Prostatectomy and Stress Urinary Incontinence (SUI) that is actively recruiting participants, run by Levee Medical. The registered enrollment target is 266 participants, above the 63-participant average among 3 other Radical Prostatectomy trials with a reported enrollment target (322% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT06873581, a Phase 3 study of Radical Prostatectomy and Stress Urinary Incontinence (SUI), is actively recruiting participants, sponsored by Levee Medical.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 266 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to compare safety and effectiveness of the Voro Urologic Scaffold in adult men undergoing robotic assisted radical prostatectomy as compared to control arm. The study is a multi-center, single blind, randomized, controlled trial. Up to 266 participants will be treated at up to 30 centers in the United States. The study will consist of a Baseline visit, implantation during robotic assisted radical prostatectomy (RARP), catheter removal, 6 weeks, 6 months, 12 months, 18 months, and 24 months.
Conditions Studied
Interventions
- DEVICE Voro Urologic Scaffold
Study Locations (20)
New York
- Northwell Health - New Hyde Park
- Memorial Sloan Kettering Cancer Center - New York
- University of Rochester Medical Center - Rochester
Tennessee
- Erlanger Urology - Chattanooga
- The Conrad Pearson Clinic - Germantown
- Urology Associates PC Nashville - Nashville
Arizona
- Mayo Clinic - Phoenix
- Academic Urology - Sun City
California
- UCLA Urology - Los Angeles
- University of California San Diego - San Diego
Maryland
- University of Maryland - Baltimore
- John Hopkins - Baltimore
Virginia
- Potomac Urology Center - Alexandria
- Urology of Virginia, PLLC - Virginia Beach
Florida
- Tampa General Hospital - Tampa
Illinois
- University of Chicago Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2025-04-18 |
| Est. Completion | 2028-02-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06873581
The ClinicalTrials.gov registry entry for NCT06873581 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 63-participant average among 3 other Radical Prostatectomy trials with a reported enrollment target (322% higher). The listed sponsor is Levee Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Radical Prostatectomy appearing as the primary indexed condition, and to 1 intervention - of which Voro Urologic Scaffold is the first listed.
NCT06873581 reports 20 study locations spanning 12 distinct geographic areas - top geographies include New York, Tennessee, Arizona.
Frequently Asked Questions
What is clinical trial NCT06873581 about?
NCT06873581 is a clinical study titled "Pivotal Study of Voro Urologic Scaffold". The objective of this study is to compare safety and effectiveness of the Voro Urologic Scaffold in adult men undergoing robotic assisted radical prostatectomy as compared to control arm. The study is a multi-center, single blind, randomized, controlled trial. Up to 266 participants will be treated...
What is the current status of trial NCT06873581?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 266 participants. The study started on 2025-04-18. Estimated completion is 2028-02-01.
What conditions does trial NCT06873581 study?
This clinical trial studies the following conditions: Radical Prostatectomy, Stress Urinary Incontinence (SUI).
What interventions are being tested in trial NCT06873581?
The interventions under investigation include: Voro Urologic Scaffold (DEVICE).
Who is sponsoring clinical trial NCT06873581?
This trial is sponsored by Levee Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06873581 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radical Prostatectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
RECRUITING · Phase 1
-
Multimodal Machine Learning Characterization of Solid Tumors
ACTIVE NOT RECRUITING
-
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.